We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Arc Growth | AGCV | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 35.00 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 35.00 |
| Top Posts |
|---|
Posted at 15/12/2005 09:53 by wonder boy Can't quite work out the Talisker Pharma investment. Why would a company with sales of $5m come to AGCV for £50,000? Their FD is no fool (Cambridge grad, CA, MBA and good experience at Glaxo) and surely there would be cheaper ways of obtaining such a small sum? Having said that the AGCV boys have pulled off some impossible sounding deals at LSV in the past. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
